|
Sangamo And Bioverativ Announce FDA Acceptance Of IND Application For ST-400
Sangamo Therapeutics, Inc. the leader in therapeutic genome editing, and Bioverativ Inc. (NASDAQ: BIVV), a global biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for hemophilia and other rare blood disorders, announced today that the U.S.
|
|
A New International Conference On The Best Of Italian Track&Trace Technologies : The Marchesini Group And Sea Vision
On October 18th, the Marchesini Group, alongside SEA Vision - the Group’s longstanding Italian partner for vision systems for pharmaceutical and OEM industries - will be at the International Conference Industry 4.0: Trends in Pharma Manufacturing...
|
|